{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-090831","form_type":"8-K","ticker":"CERO","cik":"0001870404","company_name":"CERO THERAPEUTICS HOLDINGS, INC.","filed_at":"2024-10-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.197324+00:00","generated_at":"2026-05-30T10:08:17.825664+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"CERO Therapeutics receives Nasdaq delisting notice; stock price at $0.10 or less","bullets":["Nasdaq determined to delist CERO common stock due to closing bid price ≤$0.10 for 10 consecutive days.","Company has until Oct 31, 2024 to appeal; hearing request will stay suspension pending panel decision.","Company plans to propose reverse stock split at Nov 11 special meeting to regain compliance, but approval uncertain.","Prior Bid Price Cure Period until Jan 15, 2025 is rendered unavailable by Low Priced Stocks Rule."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-090831","json":"https://secwatch.observer/filing/0001213900-24-090831.json","markdown":"https://secwatch.observer/filing/0001213900-24-090831.md","text":"https://secwatch.observer/filing/0001213900-24-090831.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1870404/000121390024090831/0001213900-24-090831-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1870404/000121390024090831/ea0218621-8k_cerothe.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T10:08:17.825664+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}